Treatment of PMR - Rituximab as a glucocorticoid sparing agent.

[Exflex]

1-year results of treatment with rituximab in polymyalgia rheumatica: an extension study of a randomised double-blind placebo-controlled

thelancet.com/journals/lanr...

After a single dose of rituximab (1000 mg), the proportion of patients with polymyalgia rheumatica in glucocorticoid-free remission remained stable at 1 year after infusion, and a glucocorticoid sparing effect was evident. A larger trial including possibility for retreatment is warranted to confirm these results.

Link came via an email which may or may not work for you. If not try searching the lancet.

[PMRpro Ambassador]

It will be interesting to see how long the remission lasts. They seem to be quite busy in the Netherlands when it comes to PMR!